WELCOME TO FIERCE LIFE SCIENCES WEEKLY DIGEST This month we’re profiling the most influential people in biopharma—and we’re starting with the CEOs. Our readers will likely be familiar with these well-known names, but there’s always more to the stories behind these leaders and their game-changing companies. We’ll be announcing five honorees each week, spanning influential scientists, entrepreneurs, regulatory experts and more. In the meantime, give a listen to our newly launched podcast, The Top Line, with our reporters talking you through the biggest news of the week. And as always, our top stories follow below. | |
|
Featured Story | By Eric Sagonowsky,Ben Adams,Angus Liu,Fraiser Kansteiner With great pleasure, the Fierce Biotech and Fierce Pharma teams bring you our 2022 selections for the most influential people in biopharma. Starting today and for following three weeks, we’ll release five honorees each Monday and tell you their stories. We will shed light on why they are significant players in their respective fields and why their peers are paying close attention to their moves. read more |
| |
|---|
|
Top Stories Of The Week By Eric Sagonowsky Amid Pfizer's run as a global vaccine heavyweight—emphasized lately by its success with COVID-19 shot, Comirnaty—the company is losing a top scientist. read more By Gabrielle Masson Messenger RNA has already proven its credentials in the race to create a COVID-19 vaccine, and researchers are investigating whether this versatile technology could also boost recovery from a heart attack. read more By Teresa Carey This week on "The Top Line," we discuss why Biogen’s overhaul reached the CEO level and dive into next steps at the company. We also discuss the most influential people in biopharma and the week's biggest headlines. read more By Ben Adams Novartis is continuing its digital push under CEO Vas Narasimhan with a new Netflix-style approach to help connect with doctors and better learn what content resonates with them. read more By Conor Hale The AI spots people whose hearts may be having trouble pumping blood out to the rest of the body. read more By Andrea Park Seemingly still dissatisfied with Philips’ handling of its ongoing respiratory device recall, the FDA is now considering taking further action to force the medtech to tighten up its response to the safety event. read more By Angus Liu Biogen’s yearlong struggle with the controversial FDA approval and launch of Aduhelm has culminated in a deep overhaul reaching all the way to the CEO. read more By Kevin Dunleavy With an FDA approval Friday afternoon for ankylosing spondylitis, AbbVie's immunology drug Rinvoq has collected its fourth nod in five months. Ironically, though, the blessing came on the same day that AbbVie reported a sales slowdown for the juggernaut. read more By Annalee Armstrong Layoffs are hitting biotech fast and furious. The Fierce Biotech Layoff Tracker is listing them all from Jan. 1 on. read more By Gabrielle Masson Another of Pfizer's gene therapies had been freed from an FDA clinical hold, but the study is not set to get underway immediately. read more By Angus Liu BeiGene has broken ground at its flagship U.S. manufacturing and clinical R&D center in New Jersey even as a Nasdaq delisting threat hangs over the company. read more By Sophia Sorensen The liver is the only organ with the power to regenerate itself, and now, with a little help, it could even get younger. Researchers at the Salk Institute have found a way to partially de-age liver cells, returning them to younger stages to improve tissue regeneration. read more Resources Sponsored by: Blue Matter, strategic consultants in the life sciences Recent trends are driving big changes in Medical Affairs. This paper explores why, and what MA teams can do to stay ahead of the curve. Sponsored by: PwC Don’t miss these critical considerations when evaluating your HCP interactions management program. Sponsored By: H1 More than 570 clinical trials in Ukraine have been disrupted. Unanticipated disruptions to medical testing and clinical trials impede progress toward new breakthroughs and new therapies that millions of patients around the world hang their hope on. What role do rescue sites play? Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. | 
